Characteristics of Responders to Biologics in Patients with Severe Asthma: Based on Precision Medicine Intervention in Severe Asthma (PRISM) Study
J. Lee (Seoul, Republic of Korea), H. Kim (Seoul, Republic of Korea), J. Jung (Seoul, Republic of Korea), M. Kim (Seoul, Republic of Korea), J. Choi (Hwaseong, Republic of Korea), J. Moon (Seoul, Republic of Korea), S. Park (Seoul, Republic of Korea), S. Kim (Seongnam, Republic of Korea), M. Yang (Seoul, Republic of Korea), B. Kim (Seoul, Republic of Korea), J. Kwon (Chuncheon, Republic of Korea), H. Park (Busan, Republic of Korea), C. Park (Busan, Republic of Korea), T. Lee (Ulsan, Republic of Korea), S. Kim (Daegu, Republic of Korea), Y. Nam (Busan, Republic of Korea), H. Park (Daegu, Republic of Korea), B. Lee (Seoul, Republic of Korea), H. Kwon (Seoul, Republic of Korea), W. Song (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea), Y. Cho (Seoul, Republic of Korea), T. Kim (Seoul, Republic of Korea)
Source: International Congress 2022 – Translational studies of asthma and COPD
Session: Translational studies of asthma and COPD
Session type: Thematic Poster
Number: 4325
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Lee (Seoul, Republic of Korea), H. Kim (Seoul, Republic of Korea), J. Jung (Seoul, Republic of Korea), M. Kim (Seoul, Republic of Korea), J. Choi (Hwaseong, Republic of Korea), J. Moon (Seoul, Republic of Korea), S. Park (Seoul, Republic of Korea), S. Kim (Seongnam, Republic of Korea), M. Yang (Seoul, Republic of Korea), B. Kim (Seoul, Republic of Korea), J. Kwon (Chuncheon, Republic of Korea), H. Park (Busan, Republic of Korea), C. Park (Busan, Republic of Korea), T. Lee (Ulsan, Republic of Korea), S. Kim (Daegu, Republic of Korea), Y. Nam (Busan, Republic of Korea), H. Park (Daegu, Republic of Korea), B. Lee (Seoul, Republic of Korea), H. Kwon (Seoul, Republic of Korea), W. Song (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea), Y. Cho (Seoul, Republic of Korea), T. Kim (Seoul, Republic of Korea). Characteristics of Responders to Biologics in Patients with Severe Asthma: Based on Precision Medicine Intervention in Severe Asthma (PRISM) Study. 4325
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|